Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,007 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort.
Hayashi N, Fukai J, Nakatogawa H, Kawaji H, Yoshioka E, Kodama Y, Nakajo K, Uda T, Naito K, Kijima N, Okita Y, Kagawa N, Takahashi Y, Hashimoto N, Arita H, Takano K, Sakamoto D, Iida T, Arakawa Y, Kawauchi T, Sonoda Y, Mitobe Y, Ishibashi K, Matsuda M, Achiha T, Tomita T, Nonaka M, Hara K, Takebe N, Tsuzuki T, Nakajima Y, Ohue S, Nakajima N, Watanabe A, Inoue A, Umegaki M, Kanematsu D, Katsuma A, Sumida M, Shofuda T, Mano M, Kinoshita M, Mori K, Nakao N, Kanemura Y. Hayashi N, et al. Among authors: takano k. Acta Neuropathol Commun. 2024 Oct 1;12(1):155. doi: 10.1186/s40478-024-01863-3. Acta Neuropathol Commun. 2024. PMID: 39354603 Free PMC article. No abstract available.
Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas.
Takano K, Kinoshita M, Arita H, Okita Y, Chiba Y, Kagawa N, Fujimoto Y, Kishima H, Kanemura Y, Nonaka M, Nakajima S, Shimosegawa E, Hatazawa J, Hashimoto N, Yoshimine T. Takano K, et al. AJNR Am J Neuroradiol. 2016 Jan;37(1):44-50. doi: 10.3174/ajnr.A4460. Epub 2015 Sep 17. AJNR Am J Neuroradiol. 2016. PMID: 26381556 Free PMC article.
Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor.
Takano K, Kinoshita M, Takagaki M, Sakai M, Tateishi S, Achiha T, Hirayama R, Nishino K, Uchida J, Kumagai T, Okami J, Kawaguchi A, Hashimoto N, Nakanishi K, Imamura F, Higashiyama M, Yoshimine T. Takano K, et al. Neuro Oncol. 2016 May;18(5):716-24. doi: 10.1093/neuonc/nov266. Epub 2015 Oct 31. Neuro Oncol. 2016. PMID: 26519739 Free PMC article.
Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma.
Sasaki T, Kinoshita M, Fujita K, Fukai J, Hayashi N, Uematsu Y, Okita Y, Nonaka M, Moriuchi S, Uda T, Tsuyuguchi N, Arita H, Mori K, Ishibashi K, Takano K, Nishida N, Shofuda T, Yoshioka E, Kanematsu D, Kodama Y, Mano M, Nakao N, Kanemura Y. Sasaki T, et al. Among authors: takano k. Sci Rep. 2019 Oct 8;9(1):14435. doi: 10.1038/s41598-019-50849-y. Sci Rep. 2019. PMID: 31594994 Free PMC article.
Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.
Yokota C, Kagawa N, Takano K, Chiba Y, Kinoshita M, Kijima N, Oji Y, Oka Y, Sugiyama H, Tsuboi A, Izumoto S, Kishima H, Hashimoto N. Yokota C, et al. Among authors: takano k. Cancer Immunol Immunother. 2022 Jan;71(1):189-201. doi: 10.1007/s00262-021-02954-z. Epub 2021 Jun 5. Cancer Immunol Immunother. 2022. PMID: 34089373 Free PMC article.
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies.
Yokota C, Nakata J, Takano K, Nakajima H, Hayashibara H, Minagawa H, Chiba Y, Hirayama R, Kijima N, Kinoshita M, Hashii Y, Tsuboi A, Oka Y, Oji Y, Kumanogoh A, Sugiyama H, Kagawa N, Kishima H. Yokota C, et al. Among authors: takano k. Neurooncol Adv. 2021 Jun 29;3(1):vdab091. doi: 10.1093/noajnl/vdab091. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34355173 Free PMC article.
Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity image.
Sanada T, Kinoshita M, Sasaki T, Yamamoto S, Fujikawa S, Fukuyama S, Hayashi N, Fukai J, Okita Y, Nonaka M, Uda T, Arita H, Mori K, Ishibashi K, Takano K, Nishida N, Shofuda T, Yoshioka E, Kanematsu D, Tanino M, Kodama Y, Mano M, Kanemura Y. Sanada T, et al. Among authors: takano k. Neurooncol Adv. 2024 Feb 1;6(1):vdae016. doi: 10.1093/noajnl/vdae016. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38410136 Free PMC article.
2,007 results